Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Psychiatry Res. 2022 Jan;307:114334. doi: 10.1016/j.psychres.2021.114334. Epub 2021 Dec 7.
SARS-CoV-2 infection causes a pulmonary disease (COVID-19) which spread worldwide generating fear, anxiety, depression in the general population as well as among subjects affected by mental disorders. Little is known about which different psychopathological changes the pandemic caused among individuals affected by different psychiatric disorders, which represents the aim of the present study. Specific psychometric scales were administered at three time points: T0 as outbreak of pandemic, T1 as lockdown period, T2 as reopening. Descriptive analyses and linear regression models were performed. A total of 166 outpatients were included. Overall, psychometric scores showed a significant worsening at T1 with a mild improvement at T2. Only psychopathology in schizophrenia (SKZ) patients and obsessive-compulsive (OC) symptoms did not significantly improve at T2. Subjects affected by personality disorders (PDs) resulted to be more compromised in terms of general psychopathology than depressed and anxiety/OC ones, and showed more severe anxiety symptoms than SKZ patients. In conclusion, subjects affected by PDs require specific clinical attention during COVID-19 pandemic. Moreover, the worsening of SKZ and OC symptoms should be strictly monitored by clinicians, as these aspects did not improve with the end of lockdown measures. Further studies on larger samples are needed to confirm our results. ClinicalTrials.gov Identifier: NCT04694482.
SARS-CoV-2 感染会导致肺部疾病(COVID-19),这种疾病在全球范围内传播,引起了公众的恐惧、焦虑和抑郁,包括患有精神障碍的人群。目前对于大流行期间不同精神障碍患者出现的不同心理病理变化知之甚少,这是本研究的目的。在三个时间点(T0 为疫情爆发时,T1 为封锁期,T2 为重新开放时)使用特定的心理计量学量表进行评估。共纳入 166 名门诊患者。总体而言,心理计量学评分在 T1 时显著恶化,在 T2 时略有改善。只有精神分裂症(SKZ)患者的精神病和强迫症状(OC)在 T2 时没有明显改善。与抑郁和焦虑/OC 患者相比,人格障碍(PD)患者的一般精神病学更差,并且比 SKZ 患者表现出更严重的焦虑症状。总之,在 COVID-19 大流行期间,PD 患者需要特别的临床关注。此外,SKZ 和 OC 症状的恶化应引起临床医生的严格监测,因为这些方面并没有随着封锁措施的结束而改善。需要进一步的研究来证实我们的结果。ClinicalTrials.gov 标识符:NCT04694482。